Business / Finance

RSS

As consumers postpone care, health insurers make record profits

The nation's major health insurers are barreling into a third year of record profits, enriched in recent months by a lingering recessionary mind-set among Americans who are postponing or forgoing medical care. The UnitedHealth Group, one of the largest commercial insurers, told analysts that so far this year, insured hospital stays actually decreased in some instances.

16 May 2011

Teva signs definitive agreement to acquire Taiyo

Teva Pharmaceutical Industries Ltd. announced today that it has signed a definitive agreement to acquire 57% of the shares in privately-held Taiyo Pharmaceutical Industry Co. Ltd. for $460 million in cash paid to private shareholders.

16 May 2011

Acuity Brands announces acquisition of Healthcare Lighting

Acuity Brands, Inc. today announced it has acquired for cash Fairview, PA-based Healthcare Lighting, Inc., a leading provider of specialized, high-performance lighting products for healthcare facilities.

13 May 2011

Antares Pharma prices underwritten public offering of common stock

Antares Pharma, Inc. today announced it has priced a firm commitment underwritten public offering of 12,500,000 shares of the Company's common stock at a purchase price of $1.60 per share for an aggregate gross offering amount of $20.0 million.

13 May 2011

Corgenix third quarter revenues down 16.7% to $1,828,943

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, today filed its third quarter Form 10-Q and reported its financial results.

13 May 2011

Biodel enters deal with Great Point Partners, Orbimed Advisors to sell 12.2 million shares of common stock

Biodel Inc. today announced that it has entered into definitive agreements with a group of institutional investors, including Great Point Partners, LLC and Orbimed Advisors, LLC, to sell approximately 12.2 million shares of its common stock, 1.7 million shares of its Series A Convertible Preferred Stock and warrants to purchase 9.0 million shares of its common stock.

13 May 2011

Diet-Bailout author use business tools for new weight loss approach

Rosemary Hershey, author of Diet-Bailout, introduces a new approach to weight loss using business tools that change the way women diet.

13 May 2011

Dr. Reddy's 2011 consolidated revenues increase 6% to Rs. 74.7 billion

Dr. Reddy's Laboratories Ltd. today announced its unaudited consolidated financial results for the quarter and full year ended March 31, 2011 under International Financial Reporting Standards.

13 May 2011

Nuvo Research acquires ZARS Pharma

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced that it has completed its acquisition of ZARS Pharma, Inc.

13 May 2011

Pro-Pharmaceuticals reports net loss of $2.7 million for first quarter 2011

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported its financial results for the first quarter, ended March 31, 2011.

13 May 2011

Researcher says a comparison with epilepsy is an appropriate prism to view economics

Since 2008, the U.S. economy has been "seizing" uncontrollably. Now a Tel Aviv University researcher says that a comparison of the multifaceted economic downturn with the uncontrolled spasms of an epileptic is not inappropriate - and may say something about the origins of the disaster.

13 May 2011

Sinovac first quarter sales increase 5.3% to $4.7 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period ended March 31, 2011.

13 May 2011

Medical Facilities first quarter revenue increases to $51.7 million

Medical Facilities Corporation, today reported its financial results for the three-month period ended March 31, 2011.

13 May 2011

ISCO announces near-term marketing plans for Lifeline Skin Care products

International Stem Cell Corporation today announced the Company's near-term marketing plans for products manufactured by its Lifeline Skin Care subsidiary.

13 May 2011

ChromaDex first quarter 2011 revenue increases 31% to $2,539,245

ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, today announced financial results for the first quarter of 2011.

12 May 2011